logo
Plus   Neg
Share
Email

EMA Accepts Astellas' Marketing Authorization Application For Roxadustat

Astellas Pharma Inc. and FibroGen Inc. (FGEN) said that the European Medicines Agency
has accepted the marketing authorization application for roxadustat for regulatory review. roxadustat is a drug for treatment of anemia in adult patients with chronic kidney disease.

EMA's acceptance of the roxadustat MAA for treatment of anemia in adult patients with chronic kidney disease on dialysis and not on dialysis triggers a milestone payment of $130 million by Astellas to FibroGen.

Chronic kidney disease is a progressive loss of kidney function caused by damage to the kidneys resulting from conditions such as hypertension, diabetes or immune-regulated inflammatory conditions.

Anemia is a common complication of CKD,resulting from the failing kidneys' diminished ability to produce erythropoietin, which stimulates red blood cell production in the bone marrow. It is associated with significant morbidity and mortality in dialysis and non-dialysis populations, increasing in both prevalence and severity as kidney disease worsens.

Anemia associated with CKD increases the risk of adverse cardiovascular events, worsens renal outcomes and can negatively impact patients' quality of life.

Roxadustat is approved and launched for the treatment of anemia associated with CKD in Japan in DD patients and in China in both DD and NDD patients. A supplemental New Drug Application has been submitted to Japan's Pharmaceuticals and Medical Devices Agency for NDD patients and a New Drug Application has been submitted in the US in both DD and NDD patients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford has revived the iconic Bronco brand after a gap of 24 years, this time as a dedicated off-road brand aiming to take on Fiat Chrysler's Jeep Wrangler, the dominant vehicle in the off-road category. Ford has introduced three new vehicles under the all-new Bronco brand as a 4x4 family of rugged SUVs under the tagline, "Built Wild". 3M Co. is teaming with researchers at Massachusetts Institute of Technology or MIT to develop a new rapid antigen test that detects the COVID-19 virus. The research, being conducted at the pilot lab facility at 3M's headquarters in St. Paul, Minnesota, is to learn if a simple-to-use, diagnostic device can produce highly accurate results within minutes and is feasible to mass manufacture. Retail giant Walmart has teamed up with the U.S. Department of Agriculture (USDA) to enable customers who pay for groceries with SNAP benefits, to gain access to Walmart's pickup and delivery service. Nearly 3,000 Walmart stores in 39 U.S. states are now offering customers receiving SNAP benefits through their Electronic Benefit Transfer (EBT) card to complete payments using the EBT card.
RELATED NEWS
Follow RTT